Gilead Sciences

NASDAQ: GILD
$76.32
+$1.61 (+2.2%)
Closing price July 10, 2020
Gilead has priced its COVID-19 drug candidate at $2,340 for a five-day treatment in the United States and some other developed countries. The company set the price for a single vial of remdesivir at...
The June 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
The new attitude among investors about sustainability and societal impact probably will dominate discussion and investment choices in the years to come. Here are five of RBC's top picks in the arena...
The May 29 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Wednesday's top analyst upgrades and downgrades included Apache, Apple, CME, Devon Energy, Diamondback Energy, Gilead Sciences, Hexo, MarketAxess, Microchip Technology and Zoom Video Communications.
The May 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks was mixed.
In a world where investors are starving to find growth, many of the well established biotech leaders and many of the large pharmaceutical companies have been acquiring growth on top of their own...
Tuesday's top analyst upgrades and downgrades included Chembio Diagnostics, Cognex, Cree, Deere, Gilead Sciences, Halliburton, iRobot, Lam Research, Nvidia, Regeneron Pharmaceuticals, Sorrento...
Tuesday's top analyst upgrades and downgrades included Beyond Meat, BioNTech, Comcast, DraftKings, Expedia, Gap, Gilead Sciences, Hess, Lululemon Athletica, Newmont and Royal Gold.
The April 30 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Gilead Sciences took another big step forward in its treatment for COVID-19 on Friday when a Japanese regulatory body approved that treatment.
Monday's top analyst upgrades and downgrades included Amazon.com, American Airlines, American Express, Beyond Meat, Caterpillar, Clorox, eBay, Gilead Sciences, Twitter, Verizon Communications and...
The April 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Monday's top analyst upgrades and downgrades included AbbVie, American Electric Power, ANGI Homeservices, DuPont, GileadSciences, Microsoft, Peloton Interactive, Shopify, Trivago and Walt Disney.
While the COVID-19 pandemic wrecked the stock market and the economy, the recent rally in the stock market has been at a time when the economic news is only getting worse and as coronavirus news...